Total Cardiology Solutions

The NHS Collaborative Procurement Partnership (NHS CPP) comprising the four NHS collaborative procurement hubs (NHS London Procurement Partnership, NHS Commercial Solutions, East of England NHS Collaborative Procurement Hub and NHS North of England Commercial Procurement Collaborative) has awarded and implemented a Total Cardiology Solutions framework agreement. The project has been led on behalf of CPC by LPP and creates a framework agreement covering the broad range of cardiology product categories on behalf of hub members, as well as being available for use by the wider NHS.

Benefits of the contract

The framework agreement provides a single framework solution for the full range of cardiology products and is designed to meet the following objectives:

Improving efficiency

  • To operate a strategic framework agreement to improve trust spend and usage data
  • To reduce the volumes of tenders conducted by NHS CPP member NHS trusts (as may change from time to time)
  • To simplify the procurement landscape in the NHS by seeking to reduce the proliferation of competing framework agreements
  • To provide a framework agreement that seeks to deliver savings towards the DH £2 billion procurement savings target.

 Improving safety

  • Release clinical time to focus on patient care
  • Reduce inventory wastage risks
  • Improve hygiene with products stored in a secure clean environment.

 Greater assurance of product availability

  • To ensure that providers are aware of the stakeholder trusts requirements;
  • Providers can deliver stakeholder trust requirements when needed; and
  • Reduce consumption rates by better control and accountability. 

 Ensure quality

  • To ensure that products and services of the right quality to meet the Member trusts' needs are made available though the framework agreement

 Enable innovation

  • To ensure that new technologies in the Cardiology category are accommodated where appropriate in the framework agreement thereby enabling access to trusts of new products at appropriate framework agreement prices through a route to market that is compliant with the Public Contracts Regulations

 Contribute towards the DH procurement savings target

  • To enable trusts to contribute towards the DH procurement target of £2 billion through improved pricing and commercial opportunities under the framework agreement
  • To enable trusts to comply with requirements under the NHS contract to achieve cost efficiencies

Contract description

The framework agreement encompasses the following lots:

Lot 1

Implantable Cardioverter Defibrillators and Pacemakers

Lot 2

Electro Physiology

Lot 3

Cardiac Stents and Transcatheter Aortic/Pulmonary Valves and Insertion Devices

Lot 4

Interventional Radiology Products used in Cardiology

Lot 5

Hypertension - including Renal Denervation solutions

Lot 6

Heart Valves

Lot 7


Lot 9

Beating Heart Surgery Products


Abbott Vascular

Acrostak-UK Ltd

Aquilant Limited T/A Aquilant Interventional

Biosensors Europe SA

Biotronik UK Ltd

Boston Scientific Ltd

CareFusion (formerly UK Medical Ltd)


Covidien (UK) Commercial Ltd

Dot Medical Ltd

Edwards Lifesciences Ltd

Inomed Health Ltd

Johnson & Johnson Medical Ltd

Kimal plc

Maquet Ltd

Medtronic Limited

Merit Medical UK Ltd.

Pierson Surgical Ltd

Sorin Group UK Ltd

St Jude Medical UK Ltd


Terumo UK Ltd

Vascular Perspectives Ltd

Vascutek UK Ltd